CAM
MNTA

Capstone Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Capstone Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$267K Sell
15,773
-1,320
-8% -$20.1K 0.01% 1346
2017
Q1 		$228K Sell
17,093
-2,020
-11% -$31.6K 0.01% 1467
2016
Q4 		$288K Buy
19,113
+1,110
+6% +$14.7K 0.01% 1342
2016
Q3 		$210K Sell
18,003
-180
-1% -$2.12K 0.01% 1506
2016
Q2 		$196K Buy
18,183
+630
+4% +$6.5K 0.01% 1515
2016
Q1 		$162K Sell
17,553
-1,460
-8% -$15.7K ﹤0.01% 1532
2015
Q4 		$282K Buy
19,013
+900
+5% +$15.1K 0.01% 1317
2015
Q3 		$297K Buy
18,113
+1,300
+8% +$26.6K 0.01% 1246
2015
Q2 		$384K Sell
16,813
-3,810
-18% -$75.9K 0.01% 1148
2015
Q1 		$313K Buy
20,623
+790
+4% +$10.3K 0.01% 1371
2014
Q4 		$239K Sell
19,833
-2,620
-12% -$29.9K 0.01% 1497
2014
Q3 		$255K Sell
22,453
-170
-0.8% -$1.94K 0.01% 1441
2014
Q2 		$273K Buy
22,623
+2,343
+12% +$27.7K 0.01% 1442
2014
Q1 		$236K Sell
20,280
-1,000
-5% -$16.9K 0.01% 1567
2013
Q4 		$376K Sell
21,280
-4,767
-18% -$80.1K 0.01% 1355
2013
Q3 		$375K Buy
26,047
+570
+2% +$8.72K 0.01% 1506
2013
Q2 		$384K Buy
+25,477
New +$336K 0.01% 1406

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Capstone Asset Management's MNTA Position: Q2 2017 in Review

Capstone Asset Management reduced its Momenta Pharmaceuticals, Inc. (MNTA) stake by 7.7% in Q2 2017, selling an estimated $20.1K and leaving 15,773 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #1346.

Capstone Asset Management first reported a position in MNTA in Q2 2013 and has held it in 17 quarters since. The position peaked at $384K in Q2 2015. 164 funds tracked by Wall St. Rank hold MNTA as of Q2 2017.

  • Capstone Asset Management held 15,773 shares of Momenta Pharmaceuticals, Inc. worth $267K as of Q2 2017.
  • Capstone Asset Management sold 1,320 Momenta Pharmaceuticals, Inc. shares in Q2 2017, an estimated $20.1K.
  • Momenta Pharmaceuticals, Inc. made up 0.01% of Capstone Asset Management's portfolio in Q2 2017, its #1346 holding.
  • Capstone Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and has held it in 17 quarters since.
  • Capstone Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $384K in Q2 2015.
  • 164 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.